MART-1 / Melan-A / MLANA (Melanoma Marker) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-MART-1 / Melan-A / MLANA (Melanoma Marker) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | MART-1 / Melan-A / MLANA (Melanoma Marker) |
| Clone | [M2-9E3] |
| Host Species | Mouse |
| Reactive Species | human, mouse, rat |
| Isotype | IgG2b, kappa |
| Format | unconjugated |
| Size | 0.02 mg (With BSA & Azide at 0.2mg/ml), 0.1 mg (With BSA & Azide at 0.2mg/ml), 0.1 mg (Without BSA & Azide at 1mg/ml) |
| Concentration | n/a |
| Applications | Flow Cytometry (FC/FACS), Immunofluorescence (IF), Western Blot (WB), Immunohistochemistry (IHC) Formalin |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This antibody recognizes a protein doublet of 20-22kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Seven other melanoma associated antigens recognized by autologous cytotoxic T cells include MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MAb labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin. |
| Immunogen | Immunogen: Recombinant hMART-1 protein |
| Other Names | [Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA], [MLANA; MLANA; MART1; MART-1; MART1; MART-1] |
| Gene, Accession # | [MLANA], Gene ID: 2315, NCBI: NP_005502.1, UniProt: Q16655 |
| Catalog # | MBS438008 |
| Price | $190, $340, $340 |
| Order / More Info | MART-1 / Melan-A / MLANA (Melanoma Marker) Antibody from MYBIOSOURCE INC. |
| Product Specific References | Kawakami Y, et. al. Journal of Immunological Methods, 1997, 202(1):13-25. Marincola FM, et. al. J of Immunotherapy with Emphasis on Tumor Immunol, 1996, 19(3):192-205 |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies